ClassID:

20918

A61K38/1709 - page 13 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#3601
20120288943
2012-11-15

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

#3602
20120288942
2012-11-15

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

#3603
20120288941
2012-11-15

Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof

#3604
20120288886
2012-11-15

Methods of identifying inhibitors of FGF23 binding to the binary FGFR-klotho complex for the treatment of hypophosphatemia

#3605
20120283191
2012-11-08

Approach to treat intraocular hypertension

#3606
20120283188
2012-11-08

Genes and proteins associated with angiogenesis and uses thereof

#3607
20120283183
2012-11-08

Method of reducing cell death by administering a paracrine factor of a mesenchymal stem cell

#3608
20120283174
2012-11-08

ANTIBIOFILM GLYCOPEPTIDES

#3609
20120282689
2012-11-08

Expanding the eukaryotic genetic code

#3610
20120277288
2012-11-01

Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification

#3611
20120277144
2012-11-01

NOVEL COMPOUNDS FOR MODULATING NEOVASCULARISATION AND METHODS OF TREATMENT USING THESE COMPOUNDS

#3612
20120276116
2012-11-01

Prevention and Treatment of Amyloidogenic Disease

#3613
20120276095
2012-11-01

B7-H4 fusion proteins and methods of use thereof

#3614
20120276021
2012-11-01

USE OF REPEAT SEQUENCE PROTEIN POLYMERS IN PERSONAL CARE COMPOSITIONS

#3615
20120271032
2012-10-25

Preparation of a Therapeutic Composition

#3616
20120270798
2012-10-25

Compositions and methods for preventing or treating cancer

#3617
20120270793
2012-10-25

METHODS OF TREATING A PATIENT RECEIVING A CARDIAC STENT IMPLANT

#3618
20120270790
2012-10-25

Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with Annexin A1 short peptide

#3619
20120270244
2012-10-25

Means and Methods for Diagnosing and/or Treating a Subject at Risk of Developing Heart Failure

#3620
20120270202
2012-10-25

Pre-Transplant Accommodated Organs Resistant To Anti-Donor Immunity

#3621
20120269880
2012-10-25

Purified amniotic membrane compositions and methods of use

#3622
20120269839
2012-10-25

HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants

#3623
20120269835
2012-10-25

Process for the production of immunogenic compositions

#3624
20120269829
2012-10-25

Inhibitors of phosphatase and tensin homolog (PTEN) conjugates

#3625
20120269806
2012-10-25

METHODS OF INDUCING TOLERANCE

#3626
20120269798
2012-10-25

Methods for identifying candidate modulators of NOTUM activity

#3627
20120269732
2012-10-25

Methods of controlling tumorigenesis and diagnosing the risk thereof

#3628
20120264677
2012-10-18

Oxidant resistant apolipoprotein A-1 and mimetic peptides

#3629
20120264106
2012-10-18

Methods for modulating inflammatory and/or immune responses

#3630
20120263684
2012-10-18

Methods for modulating inflammatory and/or immune responses

#3631
20120260344
2012-10-11

Method and system of runtime analysis

#3632
20120259091
2012-10-11

Apolipoprotein A1 Mimetics and Uses Thereof

#3633
20120258918
2012-10-11

Polypeptoid pulmonary surfactants

#3634
20120258120
2012-10-11

COMPOSITIONS AND METHODS FOR THE SYSTEMIC TREATMENT OF ARTHRITIS

#3635
20120258105
2012-10-11

Hemojuvelin fusion proteins

#3636
20120258099
2012-10-11

Inhibitors of guanine exchange factors and their use as anticancer drugs

#3637
20120253026
2012-10-04

Expanding the eukaryotic genetic code

#3638
20120253020
2012-10-04

Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways

#3639
20120252735
2012-10-04

Treatment of skin conditions by Dickkopf1 (DKK1)

#3640
20120252031
2012-10-04

Compositions and methods for regulating SAS1R

#3641
20120251615
2012-10-04

AGENT FOR INTRA-ARTICULAR INJECTION

#3642
20120251556
2012-10-04

Combination immunotherapy for the treatment of cancer

#3643
20120251457
2012-10-04

Methods and compositions for modulating adipocyte function

#3644
20120245328
2012-09-27

Charged lipoprotein complexes and their uses

#3645
20120245095
2012-09-27

Biglycan and related therapeutics and methods of use

#3646
20120244209
2012-09-27

TUSC2 THERAPIES

#3647
20120244128
2012-09-27

Perivascular stem cell composition for bone

#3648
20120238508
2012-09-20

Methods for promoting wound healing and/or reducing scar formation

#3649
20120238500
2012-09-20

REGULATION OF EPITHELIAL TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO

#3650
20120238494
2012-09-20

Methods for reducing GnRH-positive tumor cell proliferation using the GnRH antagonist IN3

#3651
20120237588
2012-09-20

METHODS OF IMPROVING CARDIAC FUNCTION AND ATTENUATING AND/OR PREVENTING CARDIAC REMODELING WITH HSP20

#3652
20120237560
2012-09-20

Cardiac Compositions

#3653
20120237472
2012-09-20

METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES USING IMMUNOMODULATORY AGENTS

#3654
20120232248
2012-09-13

THERAPEUTIC AGENT FOR PULMONARY SMALL CELL CARCINOMA

#3655
20120232005
2012-09-13

LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF

#3656
20120232001
2012-09-13

Stable formulations for parenteral injection of peptide drugs

#3657
20120231091
2012-09-13

Method for inducing differentiation of dental pulp cells into odontoblasts

#3658
20120231014
2012-09-13

Neural Regeneration

#3659
20120230975
2012-09-13

Fusion proteins

#3660
20120226090
2012-09-06

Protection Against and Treatment of Ionizing Radiation

#3661
20120225133
2012-09-06

Use of an agent that restores tissue perfusion and oxygenation

#3662
20120222141
2012-08-30

Islet1 (Isl1) and hearing loss

#3663
20120219956
2012-08-30

NGAL FOR DIAGNOSIS OF RENAL CONDITIONS

#3664
20120214737
2012-08-23

METHODS FOR PROTECTING DOPAMINERGIC NEURONS FROM STRESS AND PROMOTING PROLIFERATION AND DIFFERENTIATION OF OLIGODENDROCYTE PROGENITORS BY NRG-2

#3665
20120214235
2012-08-23

Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory

#3666
20120213858
2012-08-23

Anti-reflux infant nutrition

#3667
20120213744
2012-08-23

COMPOSITIONS AND METHODS FOR MODULATING STEM CELLS AND USES THEREOF

#3668
20120208863
2012-08-16

MODULATION OF GLUT4 GENE PROMOTER ACTIVITY BY AHNAK

#3669
20120208767
2012-08-16

Method to Detect or Treat Painful Bladder Syndrome based on Relation to Quinone Oxidoreductase 1

#3670
20120208750
2012-08-16

USE OF PROTEIN KINASE C DELTA (PKCD) INHIBITORS TO TREAT DIABETES, OBESITY, AND HEPATIC STEATOSIS

#3671
20120208745
2012-08-16

TREATMENT OF HIV

#3672
20120208743
2012-08-16

Use of gelsolin to diagnose and treat inflammatory diseases

#3673
20120207849
2012-08-16

Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment

#3674
20120207848
2012-08-16

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#3675
20120207791
2012-08-16

Immobilized biologically active entities having a high degree of biological activity

#3676
20120207775
2012-08-16

Immunogenic epitopes as targets for universal cancer vaccines

#3677
20120207737
2012-08-16

MEDICAL UTILITY OF GLYCAN-BINDING PROTEINS AND GLYCANS

#3678
20120207726
2012-08-16

Autism-associated biomarkers and uses thereof

#3679
20120207720
2012-08-16

LAMININS, DERIVATIVES, AND COMPOSITIONS INCLUDING SAME AND METHODS FOR THEIR THERAPEUTIC USE

#3680
20120207705
2012-08-16

Stem Cell Conditioned Medium Compositions

#3681
20120207704
2012-08-16

Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted Endopeptidases

#3682
20120202740
2012-08-09

SCGB3A2 as a growth factor and anti-apoptotic agent

#3683
20120201815
2012-08-09

METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST

#3684
20120195978
2012-08-02

CAPCNA PEPTIDE THERAPEUTICS FOR CANCER

#3685
20120195976
2012-08-02

METHODS OF TREATING INFLAMMATION BY ADMINISTRATION OF HEME OXYGENASE-1 AND PRODUCTS OF HEME DEGRADATION

#3686
20120195894
2012-08-02

Regulatory T cell mediator proteins and uses thereof

#3687
20120190834
2012-07-26

Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder thereapeutics

#3688
20120190727
2012-07-26

Method and means for treatment of osteoarthritis

#3689
20120190610
2012-07-26

Tetranectin-apolipoprotein A-I, lipid particles containing it and its use

#3690
20120190609
2012-07-26

METHOD FOR PRODUCING A LIPID PARTICLE, THE LIPID PARTICLE ITSELF AND ITS USE

#3691
20120189626
2012-07-26

TREATMENT OF COMPLEMENT-ASSOCIATED DISORDERS

#3692
20120189610
2012-07-26

Treatment of pain

#3693
20120183602
2012-07-19

Lipid formulation

#3694
20120183564
2012-07-19

Inhibition of endosomal toll-like receptor activation

#3695
20120183524
2012-07-19

MOLECULAR TARGETS FOR TREATMENT OF INFLAMMATION

#3696
20120177695
2012-07-12

Bioerodible silicon-based devices for delivery of therapeutic agents

#3697
20120177645
2012-07-12

Methods and compositions for the inhibition of transplant rejection

#3698
20120177619
2012-07-12

COMPOSITION COMPRISING A HAEMATIC COMPONENT AND ITS USE FOR THE TREATMENT OF DEGENERATIVE JOINT DISEASE

#3699
20120177610
2012-07-12

Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins

#3700
20120172314
2012-07-05

Klotho protein and related compounds for the treatment and diagnosis of cancer

#3701
20120172306
2012-07-05

Use of HASF as a Protective Agent Against Ischemic Tissue Damage

#3702
20120172285
2012-07-05

Methods and compositions for specific modulation of MCL-1

#3703
20120171289
2012-07-05

DELIVERY SYSTEMS FOR BIOACTIVE AGENTS

#3704
20120171210
2012-07-05

METHODS AND COMPOSITIONS FOR INHIBITING C-MET DIMERIZATION AND ACTIVATION

#3705
20120171206
2012-07-05

Methods of stimulating liver regeneration

#3706
20120167240
2012-06-28

Compositions and Methods for Modulating PGC-1Alpha to Treat Neurological Diseases and Disorders

#3707
20120165270
2012-06-28

INHIBITION OF HAIR FOLLICLE GROWTH BY THE WNT INHIBITOR DKK1

#3708
20120164656
2012-06-28

Methods To Identify Compounds Useful For The Treatment Of Proliferative And Differentiative Disorders

#3709
20120164148
2012-06-28

Compositions Containing JARID1B Inhibitors and Methods for Treating Cancer

#3710
20120159659
2012-06-21

CUSTOM-MADE MEGANUCLEASE AND USE THEREOF

#3711
20120157976
2012-06-21

Methods for treating neurological conditions and compositions and materials therefor

#3712
20120156234
2012-06-21

Means for treating synucleinopathies

#3713
20120156190
2012-06-21

Influenza prevention and treatment composition

#3714
20120156175
2012-06-21

Composition for inducing migration of neural stem cells containing periostin as effective ingredient

#3715
20120149712
2012-06-14

Methods for improving kidney function

#3716
20120149637
2012-06-14

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

#3717
20120149017
2012-06-14

DIAGNOSTIC MARKERS OF HUMAN FEMALE INFERTILITY

#3718
20120148606
2012-06-14

Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof

#3719
20120148541
2012-06-14

COMPOSITIONS AND METHODS TO GENERATE PILOSEBACEOUS UNITS

#3720
20120148529
2012-06-14

Use of Inclusion Bodies as Therapeutic Agents

#3721
20120148498
2012-06-14

Compositions and Methods for the Systemic Treatment of Arthritis

#3722
20120142762
2012-06-07

Method for preventing and treating cardiovascular diseases with BRCA1

#3723
20120142608
2012-06-07

RCA LOCUS ANALYSIS TO ASSESS SUSCEPTIBILITY TO AMD AND MPGNII

#3724
20120142588
2012-06-07

HSP therapy in conjunction with a low antigenicity diet

#3725
20120142587
2012-06-07

Liquid enteral nutritional composition with a low monovalent metal ion content

#3726
20120141590
2012-06-07

Technology for the Preparation of Microparticles

#3727
20120141489
2012-06-07

Method of treating hypertrophic cardiomyopathy

#3728
20120141448
2012-06-07

Method for increasing muscle mass and strength

#3729
20120135936
2012-05-31

Inhibition of prion propagation by receptor associated protein (RAP), its derivatives, mimetics and synthetic peptides

#3730
20120134925
2012-05-31

Application and uses of PRG4 and therapeutic modulation thereof

#3731
20120130044
2012-05-24

Stable analogs of peptide and polypeptide therapeutics

#3732
20120129776
2012-05-24

Peptide ligands for G-protein coupled receptors

#3733
20120129758
2012-05-24

Muscle function enhancing peptide

#3734
20120129757
2012-05-24

COMPOSITIONS AND METHODS FOR PROMOTING VASCULAR BARRIER FUNCTION AND TREATING PULONARY FIBROSIS

#3735
20120128701
2012-05-24

COMPOSITIONS AND METHODS FOR THE REMOVAL OF BIOFILMS

#3736
20120128659
2012-05-24

Agents capable of downregulating an MSF-A-dependent HIF-1alpha and use thereof in cancer treatment

#3737
20120122795
2012-05-17

ACCELERATED EXTENSION OF AXONS

#3738
20120122794
2012-05-17

Methods for treatment of Alzheimer's disease

#3739
20120121757
2012-05-17

Infant nutritional compositions for preventing obesity

#3740
20120121590
2012-05-17

METHODS OF INHIBITING ADVERSE CARDIAC EVENTS AND TREATING ATHEROSCLEROSIS AND CORONARY ARTERY DISEASE USING GALECTIN-3 BINDING PROTEIN (GAL-3BP, BTBD17B, MAC-2 BINDING PROTEIN)

#3741
20120121568
2012-05-17

Superoxide dismutase variants and methods of use thereof

#3742
20120115795
2012-05-10

Regulation of sodium channels by PLUNC proteins

#3743
20120115788
2012-05-10

Use of liposomal Wnt composition to enhance osseointegration

#3744
20120115771
2012-05-10

Carrier comprising a vitamin E derivative

#3745
20120114628
2012-05-10

Cosmetic and therapeutic use of proteins of DJ-1 type for treating skin dryness

#3746
20120114619
2012-05-10

PROTEIN WITH PROMOTING EFFECTS FOR AXONAL GROWTH OF NEURONS OF CENTRAL NERVOUS SYSTEM

#3747
20120108657
2012-05-03

Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2

#3748
20120108523
2012-05-03

Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells

#3749
20120108518
2012-05-03

Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain

#3750
20120108500
2012-05-03

Compositions and Methods for Modulating Immunodeficiency Virus Transcription

#3751
20120108495
2012-05-03

Method of Inhibiting Smooth Muscle Cell Proliferation by Using Reconstituted HDL

#3752
20120107336
2012-05-03

Modified defensins and their use

#3753
20120107283
2012-05-03

Human skin equivalents expressing exogenous polypeptides

#3754
20120101150
2012-04-26

Use of Vgll3 activity modulator for the modulation of adipogenesis

#3755
20120101029
2012-04-26

Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof

#3756
20120101021
2012-04-26

COMPOSITIONS, FORMULATIONS AND METHODS OF TREATING PREECLAMPSIA-TYPE DISORDERS OF PREGNANCY

#3757
20120100117
2012-04-26

METHOD FOR CHONDROGENIC DIFFERENTIATION OF PLURIPOTENT OR MULTIPOTENT STEM CELLS USING WNT6

#3758
20120094908
2012-04-19

TRUNCATED ACTIVIN TYPE II RECEPTOR AND METHODS OF USE

#3759
20120093798
2012-04-19

Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist

#3760
20120093716
2012-04-19

Use of antisecretory factors (AF) for optimizing cellular uptake

#3761
20120087910
2012-04-12

SPARC ANGIOGENIC DOMAIN AND METHODS OF USE

#3762
20120082690
2012-04-05

CHAPERONIN 10 IMMUNOSUPPRESSION

#3763
20120082644
2012-04-05

CYTOKINES AND NEUROANTIGENS FOR TREATMENT OF IMMUNE DISORDERS

#3764
20120077758
2012-03-29

INFERTILITY ASSOCIATED DEFB-126 DELETION POLYMORPHISM

#3765
20120077753
2012-03-29

JNK INHIBITORS FOR USE IN TREATING SPINAL MUSCULAR ATROPHY

#3766
20120077736
2012-03-29

Inhibitor against forming biofilm comprising κ-casein macropeptide

#3767
20120071704
2012-03-22

MITOCHONDRIAL LOCALIZATION OF MUC1

#3768
20120071629
2012-03-22

APPOPTOSIN AND USES THEREOF FOR TREATING NEURODEGENERATIVE DISEASE AND CANCER

#3769
20120071407
2012-03-22

METHOD OF TREATING WOUNDS

#3770
20120071399
2012-03-22

Sulfation of Wnt pathway proteins

#3771
20120070490
2012-03-22

Anti-trypanosomal peptides and uses thereof

#3772
20120065574
2012-03-15

Isoform Nell-1 peptide

#3773
20120064076
2012-03-15

Use of modulators of compounds of TGF-β superfamily to regulate hepcidin-mediated iron metabolism

#3774
20120064039
2012-03-15

Use of Guanylyl Cyclase C Agonists to Suppress Appetite

#3775
20120063994
2012-03-15

RTEF-1 variants and uses thereof

#3776
20120059358
2012-03-08

DNA vaccines encoding heat shock proteins

#3777
20120058955
2012-03-08

USE OF DECORINE FOR INCREASING MUSCLE MASS

#3778
20120058187
2012-03-08

WATER-IN-OIL TYPE EMULSION FOR TREATING A DISEASE OF THE EYE

#3779
20120058109
2012-03-08

Reelin rescues congnitive function

#3780
20120053128
2012-03-01

Method of inhibiting angiogenesis

#3781
20120053120
2012-03-01

Treatment of subarachnoid hemorrhage with ApoE analogs

#3782
20120053079
2012-03-01

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER

#3783
20120052080
2012-03-01

INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES

#3784
20120052077
2012-03-01

Therapeutic modulation of vaginal epithelium boundary lubrication

#3785
20120046228
2012-02-23

Methods for Modulating Ovulation

#3786
20120046217
2012-02-23

TNF-α antagonists containing IGFBP5

#3787
20120045502
2012-02-23

Antagonists of MUC1

#3788
20120041073
2012-02-16

Stabilized mutant opsin proteins

#3789
20120040893
2012-02-16

MODIFICATION OF FEEDING BEHAVIOUR

#3790
20120039949
2012-02-16

Stable Solid Formulations of GC-C Receptor Agonist Polypeptides Suitable for Oral Administration

#3791
20120039914
2012-02-16

MIF antagonists

#3792
20120039839
2012-02-16

Method for treating pulmonary hypertension

#3793
20120035106
2012-02-09

Method of inducing T cell apoptosis by administering Altered Peptide Ligand

#3794
20120035098
2012-02-09

Antiviral agent

#3795
20120034616
2012-02-09

Method for Modulating Epithelial Stem Cell Lineage

#3796
20120034166
2012-02-09

Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof

#3797
20120029473
2012-02-02

Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with Hsp60sp peptide

#3798
20120029169
2012-02-02

Methods and compositions comprising tau oligomers

#3799
20120027727
2012-02-02

TARGETED NANOPARTICLES FOR CANCER AND OTHER DISORDERS

#3800
20120027684
2012-02-02

Cancer therapy based on tumor associated antigens derived from cyclin D1

#3801
20120022000
2012-01-26

USE OF A PEPTIDE IN THE TREATMENT OR PREVENTION OF METASTASIS

#3802
20120021998
2012-01-26

Cancer Diagnosis and Treatment Methods of Use

#3803
20120021997
2012-01-26

USING HEAT SHOCK PROTEINS TO IMPROVE THE THERAPEUTIC BENEFIT OF A NON-VACCINE TREATMENT MODALITY

#3804
20120021996
2012-01-26

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

#3805
20120021982
2012-01-26

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION

#3806
20120021981
2012-01-26

Method of treatment of type-1 diabetes with humanin analogues

#3807
20120021977
2012-01-26

Promotion of healthy catch-up growth

#3808
20120021974
2012-01-26

Methods of using vimentin to inhibit angiogenesis and endothelial cell proliferation

#3809
20120021450
2012-01-26

METHODS FOR MAGNETIC RESONANCE IMAGING

#3810
20120020968
2012-01-26

Chimeric RGMa polypeptides

#3811
20120020947
2012-01-26

COMPOSITIONS AND METHODS FOR INCREASING LEAN MUSCLE MASS AFTER EXERCISE

#3812
20120015884
2012-01-19

Polypeptides for Specific Targeting to Otx2 Target Cells

#3813
20120014970
2012-01-19

Therapeutic Compositions for Treatment of Corneal Disorders

#3814
20120014965
2012-01-19

COMPOSITIONS AND METHODS OF TREATING TUMORS

#3815
20120014920
2012-01-19

Annexin and its use to treat inflammatory disorders

#3816
20120014876
2012-01-19

Antagonistic peptides for frizzled-1 and frizzled-2

#3817
20120010123
2012-01-12

Methods of administering lipocalins to treat metabolic disorders and cardiovascular diseases

#3818
20120009146
2012-01-12

Treatment of Fibrosis related disorders

#3819
20120004395
2012-01-05

Use Of Serine Protease Inhibitors In The Treatment Of Neutropenia

#3820
20120004287
2012-01-05

THERAPEUTIC AGENT COMPRISING VASOHIBIN

#3821
20120004277
2012-01-05

VECTOR(S) CONTAINING AN INDUCIBLE GENE ENCODING A CDK4/CDK6 INHIBITOR USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS OR DISEASES ASSOCIATED WITH AN UNSCHEDULED ACTIVATION OF THE CELL CYCLE

#3822
20120004175
2012-01-05

Inhibitors of NF-κB activity

#3823
20120003299
2012-01-05

Hsp9O-targeted anti-cancer chimeric peptide

#3824
20120003218
2012-01-05

ANTAGONISTS OF ACTRIIB AND USES FOR INCREASING RED BLOOD CELL LEVELS

#3825
20110318423
2011-12-29

Methods and apparatus for creating particle derivatives of HDL with reduced lipid content

#3826
20110318346
2011-12-29

Alpha B-crystallin as a therapy for ischemia or inflammation

#3827
20110312901
2011-12-22

Methods of inhibiting cell death or inflammation in a mammal by administering a BCL protein

#3828
20110312898
2011-12-22

PROPHYLACTIC / THERAPEUTIC AGENT FOR CANCER

#3829
20110312892
2011-12-22

Anxiolytic compositions containing α-casein-derived peptides

#3830
20110312872
2011-12-22

NORRIN IN THE TREATMENT OF DISEASES ASSOCIATED WITH AN INCREASED TGF-BETA ACTIVITY

#3831
20110312059
2011-12-22

TAU PROTEASE COMPOSITIONS AND METHODS

#3832
20110311554
2011-12-22

Compositions and methods for suppressing fibrocytes

#3833
20110311473
2011-12-22

Methods of treating cognitive impairment

#3834
20110306756
2011-12-15

Prevention and Treatment of Amyloidogenic Disease

#3835
20110306550
2011-12-15

ApoE analogs and methods for their use

#3836
20110305773
2011-12-15

Approach to the treatment of compartment syndrome

#3837
20110305707
2011-12-15

COMPOSITIONS AND METHODS FOR TREATING CANCER

#3838
20110305674
2011-12-15

Pathways to generate hair cells

#3839
20110305662
2011-12-15

Methods for the reactivation of latent HIV using cytosine methylation inhibitors and NF-KB activators

#3840
20110301092
2011-12-08

THE USE OF A NON-GLYCANATED POLYPEPTIDE FOR TREATING A CANCER

#3841
20110301090
2011-12-08

Skin wound healing compositions and methods of use thereof

#3842
20110300184
2011-12-08

Pharmaceutical compositions for treating or preventing bone conditions

#3843
20110294740
2011-12-01

Treatment of amyloidoses using myelin basic protein and fragments thereof

#3844
20110294739
2011-12-01

Use of the engrailed homeodomain protein as anxiolytic

#3845
20110293707
2011-12-01

Use of the cathelicidin LL-37 and derivatives thereof for wound healing

#3846
20110293689
2011-12-01

Immobilized biologically active entities having a high degree of biological activity

#3847
20110293638
2011-12-01

Method to produce an immunoglobulin preparation with improved yield

#3848
20110293635
2011-12-01

COMPOSITION AND METHODS FOR MODULATING TOLL-LIKE RECEPTOR ACTIVITY

#3849
20110293594
2011-12-01

Removal of serine proteases by treatment with finely divided silicon dioxide

#3850
20110293557
2011-12-01

CONJUGATES FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE COMPOUNDS

#3851
20110293527
2011-12-01

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#3852
20110293526
2011-12-01

COMPOSITIONS AND METHODS TO MODULATE HAIR GROWTH

#3853
20110288030
2011-11-24

Method of producing a paralytic peptide

#3854
20110288021
2011-11-24

Administration of angiocidin for the treatment of leukemia

#3855
20110287513
2011-11-24

Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof

#3856
20110287034
2011-11-24

THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS

#3857
20110287033
2011-11-24

Use of ferritin to treat iron disorders

#3858
20110287023
2011-11-24

High affinity antibodies against HMGB1 and methods of use thereof

#3859
20110286993
2011-11-24

Use of Hsp70 as a regulator of enzymatic activity

#3860
20110281938
2011-11-17

Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics

#3861
20110280828
2011-11-17

METHODS FOR TREATMENT OF MICROBIAL DISORDERS

#3862
20110275556
2011-11-10

Treatment of atherosclerosis with cholesterol ester transport protein mimotopes

#3863
20110274689
2011-11-10

COMPOUNDS AND METHODS TO MEASURE METABOLIC FUNCTION AND RESTORE NORMAL METABOLIC FUNCTION

#3864
20110269692
2011-11-03

ALPHA-FETOPROTEIN PEPTIDES AND USES THEREOF

#3865
20110269691
2011-11-03

Compositions and methods for treating pigmentary conditions and melanoma

#3866
20110269229
2011-11-03

METHODS OF INHIBITING VIRAL REPLICATION

#3867
20110268714
2011-11-03

CD34 Stem Cell-Related Methods and Compositions

#3868
20110268673
2011-11-03

Skin Treatment

#3869
20110263497
2011-10-27

Apo A-I mimetic peptides and methods of treatment

#3870
20110262485
2011-10-27

STING (STIMULATOR OF INTERFERON GENES), A REGULATOR OF INNATE IMMUNE RESPONSES

#3871
20110262458
2011-10-27

Alzheimer's Disease Treatment Method

#3872
20110262455
2011-10-27

TREATMENT OF PROLIFERATIVE DISORDERS WITH A DEATH RECEPTOR AGONIST

#3873
20110262422
2011-10-27

ORALLY ADMINISTRABLE DOSAGE FORMS COMPRISING ANGIOGENIN AND USES THEREOF

#3874
20110262396
2011-10-27

COMBINATION TREATMENTS COMPRISING PROTEASE BINDING PROTEINS FOR INFLAMMATORY DISORDERS

#3875
20110257102
2011-10-20

Compositions and methods of treating cancer

#3876
20110257101
2011-10-20

Catecholamine regulated protein

#3877
20110257094
2011-10-20

Anti periodontitis-causing microorganism agent and medical or dental materials using the same

#3878
20110256495
2011-10-20

METHODS AND RELATED KITS FOR TREATING AND REGENERATING TOOTH PULP AND PERIAPICAL TISSUES IN A MAMMAL

#3879
20110256235
2011-10-20

Compositions and methods relating to prevention of chemotherapy-induced alopecia

#3880
20110256113
2011-10-20

Method for treating diabetes using neurturin

#3881
20110250208
2011-10-13

Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor

#3882
20110250193
2011-10-13

Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease

#3883
20110250186
2011-10-13

Methods for promoting wound healing and muscle regeneration with the cell signaling protein Nell1

#3884
20110245145
2011-10-06

Methods and reagents for the diagnosis, prevention and treatment of insulin resistance using beta-arrestin2 and its up-regulators

#3885
20110244569
2011-10-06

METHOD OF INDUCING PROLIFERATION AND/OR DIFFERENTIATION OF NEURAL PRECURSOR CELLS BY INTRODUCING PROLACTIN OR WNT3A TO ACTIVATE LATENT NEURAL PRECURSOR CELLS

#3886
20110243951
2011-10-06

IMMUNOMODULATING TUMOR NECROSIS FACTOR RECEPTOR 25 (TNFR25) AGONISTS, ANTAGONISTS AND IMMUNOTOXINS

#3887
20110243921
2011-10-06

PREVENTION AND TREATMENT OF CUTANEOUS LUPUS ERYTHEMATOSUS

#3888
20110240012
2011-10-06

RECOMBINANT HUMAN CC10 AND COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF NASAL RHINITIS

#3889
20110237514
2011-09-29

PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN

#3890
20110237492
2011-09-29

TREATMENT OF DISEASES AND CONDITIONS MEDIATED BY INCREASED PHOSPHORYLATION

#3891
20110230448
2011-09-22

Treatment and/or Prevention of Non-Viral Epithelial Damage

#3892
20110230425
2011-09-22

Compositions for protection and cellular delivery of interfering RNA

#3893
20110230422
2011-09-22

PURGING OF AN EX VIVO HEMATOPOIETIC STEM CELL CULTURE OF CANCER CELLS

#3894
20110230417
2011-09-22

Treatment of diseases and conditions mediated by increased phosphorylation

#3895
20110230400
2011-09-22

NUTRITIONAL COMPOSITION FOR WOUND HEALING

#3896
20110230398
2011-09-22

Apolipoprotein C-II or its active fractions for the prevention or treatment of obesity and related metabolic disorders

#3897
20110229505
2011-09-22

Methods for the diagnosis and treatment of cancer based on AVL9

#3898
20110229504
2011-09-22

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#3899
20110229497
2011-09-22

Modulating the alternative complement pathway

#3900
20110229411
2011-09-22

USE OF P2X7 PATHWAY FOR ASSESSING THE SENSITIVITY OF A SUBJECT TO A CANCER TREATMENT